Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Benjamin Pariente
Edouard Louis

Showing results (11-20 of 364) with videos related to

Pageof 37
Sort By:
The Lancet. Gastroenterology & Hepatology|April 8, 2023
Treatment de-escalation in Crohn's disease - Author's replyEdouard Louis
Gastroenterology & Hepatology|March 21, 2025
Use of Interleukin-23 Inhibitors for the Treatment of Inflammatory Bowel DiseaseEdouard Louis
Journal of Crohn'S & Colitis|December 24, 2014
Fecal calprotectin: towards a standardized use for inflammatory bowel disease management in routine practiceEdouard Louis
Inflammatory Bowel Diseases|July 2, 2010
Immunosuppressant combined with infliximab in Crohn's Disease: for 6 months, for 2 years, or forever?Edouard Louis
Alimentary Pharmacology & Therapeutics|January 11, 2021
Editorial: keep calm and carry on-managing non-TNF antagonist biologics in pregnancy-authors' replyPauline Wils, Benjamin Pariente
La Revue Du Praticien|March 15, 2019
[Inflammatory bowel diseases in adults and children]Pauline Wils, Benjamin Pariente
La Revue Du Praticien|March 15, 2019
[Crohn's disease or ulcerative colitis?]Pauline Wils, Benjamin Pariente
Gastroenterologie Clinique Et Biologique|January 21, 2004
[Early obstructive colon after treatment of active refractory Crohn's disease with infliximab]Jacques Belaiche, Edouard Louis
The American Journal of Gastroenterology|December 21, 2002
Severe lower gastrointestinal bleeding in Crohn's disease: successful control with infliximabJacques Belaiche, Edouard Louis
Revue Medicale De Liege|June 23, 2023
[Functional colopathy : still relevant ? Let's move to irritable bowel syndrome]Pascale Latour, Edouard Louis
Pageof 37

Showing results (11-20 of 364) with videos related to

Sort By:
Pageof 37
The Lancet. Gastroenterology & Hepatology|April 8, 2023
Treatment de-escalation in Crohn's disease - Author's replyEdouard Louis
Gastroenterology & Hepatology|March 21, 2025
Use of Interleukin-23 Inhibitors for the Treatment of Inflammatory Bowel DiseaseEdouard Louis
Journal of Crohn'S & Colitis|December 24, 2014
Fecal calprotectin: towards a standardized use for inflammatory bowel disease management in routine practiceEdouard Louis
Inflammatory Bowel Diseases|July 2, 2010
Immunosuppressant combined with infliximab in Crohn's Disease: for 6 months, for 2 years, or forever?Edouard Louis
Alimentary Pharmacology & Therapeutics|January 11, 2021
Editorial: keep calm and carry on-managing non-TNF antagonist biologics in pregnancy-authors' replyPauline Wils, Benjamin Pariente
La Revue Du Praticien|March 15, 2019
[Inflammatory bowel diseases in adults and children]Pauline Wils, Benjamin Pariente
La Revue Du Praticien|March 15, 2019
[Crohn's disease or ulcerative colitis?]Pauline Wils, Benjamin Pariente
Gastroenterologie Clinique Et Biologique|January 21, 2004
[Early obstructive colon after treatment of active refractory Crohn's disease with infliximab]Jacques Belaiche, Edouard Louis
The American Journal of Gastroenterology|December 21, 2002
Severe lower gastrointestinal bleeding in Crohn's disease: successful control with infliximabJacques Belaiche, Edouard Louis
Revue Medicale De Liege|June 23, 2023
[Functional colopathy : still relevant ? Let's move to irritable bowel syndrome]Pascale Latour, Edouard Louis
Pageof 37